445 related articles for article (PubMed ID: 26516212)
21. Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson's disease.
Krauskopf J; Eggermont K; Madeiro Da Costa RF; Bohler S; Hauser D; Caiment F; de Kok TM; Verfaillie C; Kleinjans JC
Mol Psychiatry; 2022 Oct; 27(10):4355-4367. PubMed ID: 35725899
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial Phenotypes in Parkinson's Diseases-A Focus on Human iPSC-Derived Dopaminergic Neurons.
Heger LM; Wise RM; Hees JT; Harbauer AB; Burbulla LF
Cells; 2021 Dec; 10(12):. PubMed ID: 34943944
[TBL] [Abstract][Full Text] [Related]
23. Sporadic Parkinson's disease derived neuronal cells show disease-specific mRNA and small RNA signatures with abundant deregulation of piRNAs.
Schulze M; Sommer A; Plötz S; Farrell M; Winner B; Grosch J; Winkler J; Riemenschneider MJ
Acta Neuropathol Commun; 2018 Jul; 6(1):58. PubMed ID: 29986767
[TBL] [Abstract][Full Text] [Related]
24. Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients.
Tan YY; Wu L; Zhao ZB; Wang Y; Xiao Q; Liu J; Wang G; Ma JF; Chen SD
Parkinsonism Relat Disord; 2014 Mar; 20(3):308-13. PubMed ID: 24398085
[TBL] [Abstract][Full Text] [Related]
25. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress.
Nguyen HN; Byers B; Cord B; Shcheglovitov A; Byrne J; Gujar P; Kee K; Schüle B; Dolmetsch RE; Langston W; Palmer TD; Pera RR
Cell Stem Cell; 2011 Mar; 8(3):267-80. PubMed ID: 21362567
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.
Kantor B; Tagliafierro L; Gu J; Zamora ME; Ilich E; Grenier C; Huang ZY; Murphy S; Chiba-Falek O
Mol Ther; 2018 Nov; 26(11):2638-2649. PubMed ID: 30266652
[TBL] [Abstract][Full Text] [Related]
27. Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease.
Mutez E; Nkiliza A; Belarbi K; de Broucker A; Vanbesien-Mailliot C; Bleuse S; Duflot A; Comptdaer T; Semaille P; Blervaque R; Hot D; Leprêtre F; Figeac M; Destée A; Chartier-Harlin MC
Neurobiol Dis; 2014 Mar; 63():165-70. PubMed ID: 24269915
[TBL] [Abstract][Full Text] [Related]
28. Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease.
di Domenico A; Carola G; Calatayud C; Pons-Espinal M; Muñoz JP; Richaud-Patin Y; Fernandez-Carasa I; Gut M; Faella A; Parameswaran J; Soriano J; Ferrer I; Tolosa E; Zorzano A; Cuervo AM; Raya A; Consiglio A
Stem Cell Reports; 2019 Feb; 12(2):213-229. PubMed ID: 30639209
[TBL] [Abstract][Full Text] [Related]
29. Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons.
Zambon F; Cherubini M; Fernandes HJR; Lang C; Ryan BJ; Volpato V; Bengoa-Vergniory N; Vingill S; Attar M; Booth HDE; Haenseler W; Vowles J; Bowden R; Webber C; Cowley SA; Wade-Martins R
Hum Mol Genet; 2019 Jun; 28(12):2001-2013. PubMed ID: 30753527
[TBL] [Abstract][Full Text] [Related]
30. Induced pluripotent stem cell-based modeling of mutant LRRK2-associated Parkinson's disease.
Weykopf B; Haupt S; Jungverdorben J; Flitsch LJ; Hebisch M; Liu GH; Suzuki K; Belmonte JCI; Peitz M; Blaess S; Till A; Brüstle O
Eur J Neurosci; 2019 Feb; 49(4):561-589. PubMed ID: 30656775
[TBL] [Abstract][Full Text] [Related]
31. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
Zuo L; Motherwell MS
Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
[TBL] [Abstract][Full Text] [Related]
32. Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons.
Weiss A; Sommer P; Wilbertz JH
J Vis Exp; 2023 Jul; (197):. PubMed ID: 37486112
[TBL] [Abstract][Full Text] [Related]
33. LRRK2 and mitochondria: Recent advances and current views.
Singh A; Zhi L; Zhang H
Brain Res; 2019 Jan; 1702():96-104. PubMed ID: 29894679
[TBL] [Abstract][Full Text] [Related]
34. Dopaminergic neurons differentiating from LRRK2 G2019S induced pluripotent stem cells show early neuritic branching defects.
Borgs L; Peyre E; Alix P; Hanon K; Grobarczyk B; Godin JD; Purnelle A; Krusy N; Maquet P; Lefebvre P; Seutin V; Malgrange B; Nguyen L
Sci Rep; 2016 Sep; 6():33377. PubMed ID: 27640816
[TBL] [Abstract][Full Text] [Related]
35. What we can learn from iPSC-derived cellular models of Parkinson's disease.
Caiazza MC; Lang C; Wade-Martins R
Prog Brain Res; 2020; 252():3-25. PubMed ID: 32247368
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's disease.
Chen ZC; Zhang W; Chua LL; Chai C; Li R; Lin L; Cao Z; Angeles DC; Stanton LW; Peng JH; Zhou ZD; Lim KL; Zeng L; Tan EK
Sci Signal; 2017 Jul; 10(488):. PubMed ID: 28720718
[TBL] [Abstract][Full Text] [Related]
37. The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis.
Zhou ZD; Saw WT; Ho PGH; Zhang ZW; Zeng L; Chang YY; Sun AXY; Ma DR; Wang HY; Zhou L; Lim KL; Tan EK
Cell Mol Life Sci; 2022 Nov; 79(12):599. PubMed ID: 36409355
[TBL] [Abstract][Full Text] [Related]
38. The parkinson's disease-associated LRRK2 mutation R1441G inhibits neuronal differentiation of neural stem cells.
Bahnassawy L; Nicklas S; Palm T; Menzl I; Birzele F; Gillardon F; Schwamborn JC
Stem Cells Dev; 2013 Sep; 22(18):2487-96. PubMed ID: 23600457
[TBL] [Abstract][Full Text] [Related]
39. Generation of induced pluripotent stem cells (NIMHi001-A) from a Parkinson's disease patient of East Indian ethnicity carrying LRRK2 I1371V variant.
Datta I; Sowmithra ; Jagtap S; Potdar C; Yadav R; Pal P
Stem Cell Res; 2020 Apr; 44():101768. PubMed ID: 32244201
[TBL] [Abstract][Full Text] [Related]
40. High-content phenotyping of Parkinson's disease patient stem cell-derived midbrain dopaminergic neurons using machine learning classification.
Vuidel A; Cousin L; Weykopf B; Haupt S; Hanifehlou Z; Wiest-Daesslé N; Segschneider M; Lee J; Kwon YJ; Peitz M; Ogier A; Brino L; Brüstle O; Sommer P; Wilbertz JH
Stem Cell Reports; 2022 Oct; 17(10):2349-2364. PubMed ID: 36179692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
